🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 7 Days
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(16)
All (208)
Buys (16)
Sells (192)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Oncotelic Therapeutics, Inc.
(OTLC)
Trieu Vuong
— Director
Jun 17, 2026
Purchase
Shares
239,759
Price
$0.04
Total Value
$10.69K
Shares Held After
93,629,319
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PROTHENA CORP PUBLIC LTD CO
(PRTA)
SCULLY WILLIAM P
— 10% Owner
Jun 16, 2026
Purchase
Shares
20,000
Price
$7.90
Total Value
$157.99K
Shares Held After
756,000
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NeuroSense Therapeutics Ltd.
(NRSN)
Ben-Noon Alon
— Chief Executive Officer
Jun 16, 2026
Purchase
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
4,534,233
% of Holdings
5.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NeuroSense Therapeutics Ltd.
(NRSN)
Eisenberg Or
— Chief Financial Officer
Jun 16, 2026
Purchase
Shares
250,000
Price
$0.80
Total Value
$200.00K
Shares Held After
1,504,050
% of Holdings
16.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Anixa Biosciences Inc
(ANIX)
Titterton Lewis H jr
— Director
Jun 16, 2026
Purchase
Shares
2,836
Price
$2.64
Total Value
$7.49K
Shares Held After
972,170
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Artiva Biotherapeutics, Inc.
(ARTV)
RA CAPITAL MANAGEMENT, L.P.
— Director
Jun 16, 2026
Purchase
Shares
124,893
Price
$8.89
Total Value
$1.11M
Shares Held After
16,763,043
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oncotelic Therapeutics, Inc.
(OTLC)
Trieu Vuong
— Director
Jun 15, 2026
Purchase
Shares
96,000
Price
$0.04
Total Value
$4.32K
Shares Held After
93,389,560
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ocugen, Inc.
(OCGN)
Johnson-Greene Treerita Essalima
— Chief Financial Officer
Jun 15, 2026
Purchase
Shares
21,000
Price
$1.23
Total Value
$25.83K
Shares Held After
521,000
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Keros Therapeutics, Inc.
(KROS)
BIENAIME JEAN JACQUES
— Director
Jun 15, 2026
Purchase
Shares
1,000
Price
$10.19
Total Value
$10.19K
Shares Held After
17,592
% of Holdings
5.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Artiva Biotherapeutics, Inc.
(ARTV)
RA CAPITAL MANAGEMENT, L.P.
— Director
Jun 15, 2026
Purchase
Shares
15,414
Price
$8.99
Total Value
$138.57K
Shares Held After
16,638,150
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Young David
— Director
Jun 15, 2026
Purchase
Shares
2,067
Price
$2.22
Total Value
$4.59K
Shares Held After
19,198
% of Holdings
10.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Ng George K
— Director
Jun 15, 2026
Purchase
Shares
2,465
Price
$2.22
Total Value
$5.47K
Shares Held After
12,435
% of Holdings
19.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
SKIBSTED RUSSELL
— Chief Financial Officer
Jun 15, 2026
Purchase
Shares
2,654
Price
$2.22
Total Value
$5.89K
Shares Held After
13,412
% of Holdings
19.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Immuneering Corp
(IMRX)
Hall Brett Matthew
— CHIEF SCIENTIFIC OFFICER
Jun 15, 2026
Purchase
Shares
6,035
Price
$4.15
Total Value
$25.05K
Shares Held After
382,531
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Lin Patrick
— Chief Business - Strategy Off
Jun 15, 2026
Purchase
Shares
1,831
Price
$2.22
Total Value
$4.06K
Shares Held After
11,007
% of Holdings
16.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Guy Wendy
— Chief Administrative Officer
Jun 15, 2026
Purchase
Shares
2,118
Price
$2.22
Total Value
$4.70K
Shares Held After
11,958
% of Holdings
17.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Showing 1–16 of 16 transactions (page 1 of 1)
Version: v26.5.2